CAMBRIDGE, Mass., Sept. 6,
2023 /PRNewswire/ -- Akebia Therapeutics,
Inc. (Nasdaq: AKBA), a biopharmaceutical company with the
purpose to better the lives of people impacted by kidney disease,
today announced that John Butler,
Chief Executive Officer, will present at the H.C. Wainwright
25th Annual Global Investment Conference on Monday, September 11, 2023 at 9:30 a.m. ET.
The H.C. Wainwright Global Investment Conference will take place
September 11-13, 2023, in New
York.
A webcast of the presentation can be accessed through the
Investors section of Akebia's website at
https://ir.akebia.com. A replay of the webcast will also be
available for approximately 90 days following the conference
through the Investors section of Akebia's website at
https://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is
a fully integrated biopharmaceutical company with the purpose to
better the lives of people impacted by kidney disease. Akebia was
founded in 2007 and is headquartered in Cambridge, Massachusetts. For more
information, please visit our website at www.akebia.com, which does
not form a part of this release.
Akebia Therapeutics Contact
Mercedes Carrasco
Mcarrasco@akebia.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-hc-wainwright-global-investment-conference-301918518.html
SOURCE Akebia Therapeutics